Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Other peptides under investigation Several additional peptides are being studied for disc-related applications, though with less established evidence: Vasoactive Intestinal Peptide (VIP) has demonstrated the ability to slow disc degeneration progression and improve aggrecan levels in mouse studies
Development is being led by Novo Nordisk, the same company behind semaglutide (Ozempic, Wegovy)
BLL Peptides does not sell generic overseas-sourced peptides
US$ 27.50
US$ 27.57
US$ 27.99
US$ 23.44
